Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment?
作者信息
Beggiato Sarah, Zuccarini Mariachiara, Cassano Tommaso, Borroto-Escuela Dasiel Oscar, Di Iorio Patrizia, Schwarcz Robert, Fuxe Kjell, Ferraro Luca
机构信息
Department of Medical, Oral and Biotechnological Sciences, University of Chieti-Pescara, Chieti, Italy.
Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
出版信息
Front Pharmacol. 2021 Apr 14;12:654426. doi: 10.3389/fphar.2021.654426. eCollection 2021.
Abstract
摘要
相似文献
1
Adenosine and Kynurenic Acid Interactions: Possible Relevance for Schizophrenia Treatment?腺苷与犬尿氨酸的相互作用：对精神分裂症治疗是否可能具有相关性？
Front Pharmacol. 2021 Apr 14;12:654426. doi: 10.3389/fphar.2021.654426. eCollection 2021.
2
Adenosine A2A-D2 receptor-receptor interactions in putative heteromers in the regulation of the striato-pallidal gaba pathway: possible relevance for parkinson's disease and its treatment.纹状体苍白球γ-氨基丁酸（GABA）通路调节中假定异聚体中腺苷A2A受体与多巴胺D2受体的相互作用：对帕金森病及其治疗的潜在意义
Curr Protein Pept Sci. 2014;15(7):673-80. doi: 10.2174/1389203715666140901103205.
3
The kynurenine pathway in schizophrenia and bipolar disorder.精神分裂症和双相情感障碍中的犬尿氨酸途径。
Neuropharmacology. 2017 Jan;112(Pt B):297-306. doi: 10.1016/j.neuropharm.2016.05.020. Epub 2016 May 28.
4
Maternal genotype determines kynurenic acid levels in the fetal brain: Implications for the pathophysiology of schizophrenia.母体基因型决定胎儿大脑中犬尿酸的水平：对精神分裂症病理生理学的影响。
J Psychopharmacol. 2018 Nov;32(11):1223-1232. doi: 10.1177/0269881118805492. Epub 2018 Oct 24.
5
Adenosine A1-A2A receptor heteromers: new targets for caffeine in the brain.腺苷A1 - A2A受体异聚体：大脑中咖啡因的新靶点。
Front Biosci. 2008 Jan 1;13:2391-9. doi: 10.2741/2852.
6
Adenosine receptor-dopamine receptor interactions in the basal ganglia and their relevance for brain function.基底神经节中腺苷受体与多巴胺受体的相互作用及其与脑功能的相关性。
Physiol Behav. 2007 Sep 10;92(1-2):210-7. doi: 10.1016/j.physbeh.2007.05.034. Epub 2007 May 21.
7
Adenosine A2A receptors and basal ganglia physiology.腺苷A2A受体与基底神经节生理学
Prog Neurobiol. 2007 Dec;83(5):277-92. doi: 10.1016/j.pneurobio.2007.05.001. Epub 2007 Jun 26.
8
Understanding the role of heteroreceptor complexes in the central nervous system.了解异受体复合物在中枢神经系统中的作用。
Curr Protein Pept Sci. 2014;15(7):647. doi: 10.2174/138920371507140916122738.
9
Behavioral control by striatal adenosine A -dopamine D receptor heteromers.纹状体腺苷A-多巴胺D受体异聚体对行为的控制
Genes Brain Behav. 2018 Apr;17(4):e12432. doi: 10.1111/gbb.12432. Epub 2017 Nov 17.
10
Reversal of imbalance between kynurenic acid and 3-hydroxykynurenine by antipsychotics in medication-naïve and medication-free schizophrenic patients.抗精神病药对未经药物治疗和无药物治疗的精神分裂症患者犬尿氨酸和 3-羟基犬尿氨酸之间失衡的逆转。
Brain Behav Immun. 2011 Nov;25(8):1576-81. doi: 10.1016/j.bbi.2011.05.005. Epub 2011 May 17.
引用本文的文献
1
The integrative role of G protein-coupled receptor heterocomplexes in Parkinson's disease.G蛋白偶联受体异源复合物在帕金森病中的整合作用。
Neural Regen Res. 2022 Oct;17(10):2211-2212. doi: 10.4103/1673-5374.335792.
2
Molecular Integration in Adenosine Heteroreceptor Complexes Through Allosteric and De-Phosphorylation (STEP) Mechanisms and its Role in Brain Disease.通过变构和去磷酸化（STEP）机制实现腺苷异源受体复合物中的分子整合及其在脑部疾病中的作用
Front Pharmacol. 2022 Jan 5;12:781381. doi: 10.3389/fphar.2021.781381. eCollection 2021.
3
A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia.精神分裂症中犬尿氨酸途径与自主神经失衡的潜在接口。
Int J Mol Sci. 2021 Sep 16;22(18):10016. doi: 10.3390/ijms221810016.
本文引用的文献
1
Kynurenine Pathway of Tryptophan Metabolism in Neuropsychiatric Disorders: Pathophysiologic and Therapeutic Considerations.神经精神疾病中色氨酸代谢的犬尿氨酸途径：病理生理与治疗考量
Clin Psychopharmacol Neurosci. 2020 Nov 30;18(4):507-526. doi: 10.9758/cpn.2020.18.4.507.
2
Decreased striatal adenosine A-dopamine D receptor heteromerization in schizophrenia.精神分裂症中纹状体腺苷A-多巴胺D受体异聚体减少。
Neuropsychopharmacology. 2021 Feb;46(3):665-672. doi: 10.1038/s41386-020-00872-9. Epub 2020 Oct 3.
3
N-Acetylcysteine Inhibits Kynurenine Aminotransferase II.N-乙酰半胱氨酸抑制犬尿氨酸转氨酶II。
Neuroscience. 2020 Sep 15;444:160-169. doi: 10.1016/j.neuroscience.2020.07.049. Epub 2020 Aug 5.
4
Multiple Adenosine-Dopamine (A2A-D2 Like) Heteroreceptor Complexes in the Brain and Their Role in Schizophrenia.脑内多种腺苷-多巴胺（A2A-D2 样）异源受体复合物及其在精神分裂症中的作用。
Cells. 2020 Apr 27;9(5):1077. doi: 10.3390/cells9051077.
5
Potential antipsychotic action of the selective agonist of adenosine A1 receptors, 5'-Cl-5'-deoxy-ENBA, in amphetamine and MK-801 rat models.选择性腺苷 A1 受体激动剂 5'-Cl-5'-脱氧 ENBA 在安非他命和 MK-801 大鼠模型中的潜在抗精神病作用。
Pharmacol Rep. 2020 Jun;72(3):580-588. doi: 10.1007/s43440-020-00093-3. Epub 2020 Mar 26.
6
Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task.α7 型烟碱型乙酰胆碱受体和 NMDA 受体的激活对于工作记忆任务的表现是必要的。
Psychopharmacology (Berl). 2020 Jun;237(6):1723-1735. doi: 10.1007/s00213-020-05495-y. Epub 2020 Mar 11.
7
The origin of NMDA receptor hypofunction in schizophrenia.精神分裂症中 NMDA 受体功能低下的起源。
Pharmacol Ther. 2020 Jan;205:107426. doi: 10.1016/j.pharmthera.2019.107426. Epub 2019 Oct 16.
8
Conventional and Novel Pharmacological Approaches to Treat Dopamine-Related Disorders: Focus on Parkinson's Disease and Schizophrenia.治疗多巴胺相关疾病的传统和新型药理学方法：聚焦于帕金森病和精神分裂症
Neuroscience. 2020 Jul 15;439:301-318. doi: 10.1016/j.neuroscience.2019.07.026. Epub 2019 Jul 23.
9
NMDA receptor hypofunction for schizophrenia revisited: Perspectives from epigenetic mechanisms.重新审视精神分裂症的 NMDA 受体功能低下：表观遗传机制的观点。
Schizophr Res. 2020 Mar;217:60-70. doi: 10.1016/j.schres.2019.03.010. Epub 2019 Apr 9.
10
Adenosine heteroreceptor complexes in the basal ganglia are implicated in Parkinson's disease and its treatment.基底神经节中的腺苷异源受体复合物与帕金森病及其治疗有关。
J Neural Transm (Vienna). 2019 Apr;126(4):455-471. doi: 10.1007/s00702-019-01969-2. Epub 2019 Jan 14.
Zotero 插件